599 related articles for article (PubMed ID: 15505105)
1. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.
Grüner S; Prostredna M; Aktas B; Moers A; Schulte V; Krieg T; Offermanns S; Eckes B; Nieswandt B
Circulation; 2004 Nov; 110(18):2946-51. PubMed ID: 15505105
[TBL] [Abstract][Full Text] [Related]
2. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.
Lecut C; Schoolmeester A; Kuijpers MJ; Broers JL; van Zandvoort MA; Vanhoorelbeke K; Deckmyn H; Jandrot-Perrus M; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1727-33. PubMed ID: 15231520
[TBL] [Abstract][Full Text] [Related]
3. Role of murine integrin alpha2beta1 in thrombus stabilization and embolization: contribution of thromboxane A2.
Kuijpers MJ; Pozgajova M; Cosemans JM; Munnix IC; Eckes B; Nieswandt B; Heemskerk JW
Thromb Haemost; 2007 Nov; 98(5):1072-80. PubMed ID: 18000613
[TBL] [Abstract][Full Text] [Related]
4. Complementary roles of glycoprotein VI and alpha2beta1 integrin in collagen-induced thrombus formation in flowing whole blood ex vivo.
Kuijpers MJ; Schulte V; Bergmeier W; Lindhout T; Brakebusch C; Offermanns S; Fässler R; Heemskerk JW; Nieswandt B
FASEB J; 2003 Apr; 17(6):685-7. PubMed ID: 12586747
[TBL] [Abstract][Full Text] [Related]
5. G13 is an essential mediator of platelet activation in hemostasis and thrombosis.
Moers A; Nieswandt B; Massberg S; Wettschureck N; Grüner S; Konrad I; Schulte V; Aktas B; Gratacap MP; Simon MI; Gawaz M; Offermanns S
Nat Med; 2003 Nov; 9(11):1418-22. PubMed ID: 14528298
[TBL] [Abstract][Full Text] [Related]
6. A small-molecule inhibitor of integrin alpha2 beta1 introduces a new strategy for antithrombotic therapy.
Nissinen L; Pentikäinen OT; Jouppila A; Käpylä J; Ojala M; Nieminen J; Lipsanen A; Lappalainen H; Eckes B; Johnson MS; Lassila R; Marjamäki A; Heino J
Thromb Haemost; 2010 Feb; 103(2):387-97. PubMed ID: 20126829
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein VI/Fc receptor gamma chain-independent tyrosine phosphorylation and activation of murine platelets by collagen.
Jarvis GE; Best D; Watson SP
Biochem J; 2004 Nov; 383(Pt. 3):581-8. PubMed ID: 15283702
[TBL] [Abstract][Full Text] [Related]
8. Involvement of activated integrin alpha2beta1 in the firm adhesion of platelets onto a surface of immobilized collagen under flow conditions.
Moroi M; Onitsuka I; Imaizumi T; Jung SM
Thromb Haemost; 2000 May; 83(5):769-76. PubMed ID: 10823276
[TBL] [Abstract][Full Text] [Related]
9. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen.
Nieswandt B; Brakebusch C; Bergmeier W; Schulte V; Bouvard D; Mokhtari-Nejad R; Lindhout T; Heemskerk JW; Zirngibl H; Fässler R
EMBO J; 2001 May; 20(9):2120-30. PubMed ID: 11331578
[TBL] [Abstract][Full Text] [Related]
10. Differential roles of integrins alpha2beta1 and alphaIIbbeta3 in collagen and CRP-induced platelet activation.
Jarvis GE; Best D; Watson SP
Platelets; 2004 Aug; 15(5):303-13. PubMed ID: 15370101
[TBL] [Abstract][Full Text] [Related]
11. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.
Penz S; Reininger AJ; Brandl R; Goyal P; Rabie T; Bernlochner I; Rother E; Goetz C; Engelmann B; Smethurst PA; Ouwehand WH; Farndale R; Nieswandt B; Siess W
FASEB J; 2005 Jun; 19(8):898-909. PubMed ID: 15923400
[TBL] [Abstract][Full Text] [Related]
12. Platelet collagen receptors, signaling and antagonism: emerging approaches for the prevention of intravascular thrombosis.
Surin WR; Barthwal MK; Dikshit M
Thromb Res; 2008; 122(6):786-803. PubMed ID: 18045662
[TBL] [Abstract][Full Text] [Related]
13. Platelet adhesion to collagen.
Nuyttens BP; Thijs T; Deckmyn H; Broos K
Thromb Res; 2011 Jan; 127 Suppl 2():S26-9. PubMed ID: 21193111
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of reduced glycoprotein VI levels on activation of murine platelets by glycoprotein VI ligands.
Snell DC; Schulte V; Jarvis GE; Arase K; Sakurai D; Saito T; Watson SP; Nieswandt B
Biochem J; 2002 Nov; 368(Pt 1):293-300. PubMed ID: 12117414
[TBL] [Abstract][Full Text] [Related]
15. Binding of galectin-1 to αIIbβ₃ integrin triggers "outside-in" signals, stimulates platelet activation, and controls primary hemostasis.
Romaniuk MA; Croci DO; Lapponi MJ; Tribulatti MV; Negrotto S; Poirier F; Campetella O; Rabinovich GA; Schattner M
FASEB J; 2012 Jul; 26(7):2788-98. PubMed ID: 22456341
[TBL] [Abstract][Full Text] [Related]
16. Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity.
Nonne C; Lenain N; Hechler B; Mangin P; Cazenave JP; Gachet C; Lanza F
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1293-8. PubMed ID: 15774906
[TBL] [Abstract][Full Text] [Related]
17. Glybenclamide: an antidiabetic with in vivo antithrombotic activity.
Ting HJ; Khasawneh FT
Eur J Pharmacol; 2010 Dec; 649(1-3):249-54. PubMed ID: 20858477
[TBL] [Abstract][Full Text] [Related]
18. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
[TBL] [Abstract][Full Text] [Related]
19. Diversity of signaling underlying responses mediated by selective activation of the platelet thromboxane A2 (TXA2) receptor; pharmacological and kinetic studies in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003 Sep; 14(6):359-74. PubMed ID: 14602550
[TBL] [Abstract][Full Text] [Related]
20. Critical roles for the actin cytoskeleton and cdc42 in regulating platelet integrin alpha2beta1.
Pula G; Poole AW
Platelets; 2008 May; 19(3):199-210. PubMed ID: 18432521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
